Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Home
Profiles
Research units
Equipment
Research output
Press/Media
Search by expertise, name or affiliation
Treatment of chronic hepatitis C
Yun Jung Chang
*
, Kwan Soo Byun
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of chronic hepatitis C'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Hepatitis C
100%
Interferon-α (IFN-α)
75%
PEGylated
75%
Response Rate
50%
Combination Therapy
50%
Sustained Virological Response
50%
Ribavirin
50%
Genotype 2
25%
Hepatocellular Carcinoma
25%
Previous Treatment
25%
Chronic Infection
25%
Response Predictors
25%
Genotype 3
25%
Treatment-related Adverse Events
25%
New Agents
25%
Most Common Cause
25%
Treatment Goals
25%
Response Monitoring
25%
End-stage Liver Disease
25%
Objective Outcome
25%
Optimal Regimen
25%
Retreatment
25%
New Regimen
25%
Genotype 1
25%
Special Patient Groups
25%
Optimal Predictor
25%
Oral Ribavirin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis C
100%
Alpha Interferon
75%
Ribavirin
75%
Combination Therapy
50%
Adverse Event
25%
Infection
25%
Liver Cell Carcinoma
25%
End Stage Liver Disease
25%